BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 28, 2004
View Archived Issues
Acadia, Critical Therapeutics Price In 'Not A Robust Market'
Two more biotech companies went public Thursday, but as has been the case lately, their offerings brought in less than first expected. (BioWorld Today)
Read More
With MyVax In Phase III, Genitope Raising $51.8M In Public Offering
Read More
Chiron Gains Vaccine Contract Against Avian Influenza Strain
Read More
Syrrx Receives Milestone From Biogen Idec In Target Agreement
Read More
Holiday Notice
Read More
Other News To Note
Read More
Appointments And Advancements
Read More